blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1405560

EP1405560 - IL-18 TRANSGENIC ANIMAL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.08.2012
Database last updated on 03.10.2024
Most recent event   Tooltip30.05.2014Lapse of the patent in a contracting state
New state(s): LU
published on 02.07.2014  [2014/27]
Applicant(s)For all designated states
Taiho Pharmaceutical Co., Ltd.
27 Kanda Nishiki-cho 1-chome
Chiyoda-ku
Tokyo 101-8444 / JP
For all designated states
Nakanishi, Kenji
7-7-7, Nakayamasakuradai Takarazuka-shi
Hyogo 665-0877 / JP
For all designated states
Mizutani, Hitoshi
10-41, Oozono-cho Tsu-shi
Mie 514-0046 / JP
[2011/42]
Former [2004/15]For all designated states
TAIHO PHARMACEUTICAL COMPANY LIMITED
27 Kanda Nishiki-cho 1-chome
Chiyoda-ku, Tokyo 101-8444 / JP
For all designated states
Nakanishi, Kenji
7-7-7, Nakayamasakuradai
Takarazuka-shi, Hyogo 665-0877 / JP
For all designated states
Mizutani, Hitoshi
10-41, Oozono-cho
Tsu-shi, Mie 514-0046 / JP
Inventor(s)01 / MIZUTANI, Hitoshi
10-41, Ozono-cho
Tsu-shi, Mie 514-0046 / JP
 [2004/15]
Representative(s)Hartz, Nikolai
Wächtershäuser & Hartz
Patentanwaltspartnerschaft mbB
Weinstrasse 8
80333 München / DE
[N/P]
Former [2011/42]Hartz, Nikolai
Wächtershäuser & Hartz Patentanwaltspartnerschaft Weinstrasse 8
80333 München / DE
Former [2004/15]Hartz, Nikolai F., Dr.
Wächtershäuser & Hartz Patentanwälte Weinstrasse 8
80333 München / DE
Application number, filing date02745959.311.07.2002
[2004/15]
WO2002JP07047
Priority number, dateJP2001021221812.07.2001         Original published format: JP 2001212218
[2004/15]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03005811
Date:23.01.2003
Language:EN
[2003/04]
Type: A1 Application with search report 
No.:EP1405560
Date:07.04.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 23.01.2003 takes the place of the publication of the European patent application.
[2004/15]
Type: B1 Patent specification 
No.:EP1405560
Date:19.10.2011
Language:EN
[2011/42]
Search report(s)International search report - published on:JP23.01.2003
(Supplementary) European search report - dispatched on:EP08.08.2007
ClassificationIPC:A01K67/027, G01N33/15, G01N33/50, A61K45/00, A61P17/00, A61P37/08
[2004/15]
CPC:
C12N15/8509 (EP,US); A01K67/0275 (EP,US); A61P17/00 (EP);
A61P37/08 (EP); G01N33/6869 (EP,US); A01K2217/05 (EP,US);
A01K2227/105 (EP,US); A01K2267/0325 (EP,US); C12N2830/008 (EP,US);
G01N2500/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/15]
TitleGerman:IL-18 TRANSGENES TIER[2004/15]
English:IL-18 TRANSGENIC ANIMAL[2004/15]
French:ANIMAL TRANSGENIQUE IL-18[2004/15]
Entry into regional phase09.01.2004Translation filed 
09.01.2004National basic fee paid 
09.01.2004Search fee paid 
09.01.2004Designation fee(s) paid 
09.01.2004Examination fee paid 
Examination procedure27.12.2002Request for preliminary examination filed
International Preliminary Examining Authority: JP
09.01.2004Examination requested  [2004/15]
23.03.2009Despatch of a communication from the examining division (Time limit: M04)
08.07.2009Reply to a communication from the examining division
05.10.2010Despatch of a communication from the examining division (Time limit: M04)
26.11.2010Reply to a communication from the examining division
20.04.2011Communication of intention to grant the patent
17.08.2011Fee for grant paid
17.08.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.03.2009
Opposition(s)20.07.2012No opposition filed within time limit [2012/39]
Fees paidRenewal fee
23.07.2004Renewal fee patent year 03
25.07.2005Renewal fee patent year 04
24.07.2006Renewal fee patent year 05
05.07.2007Renewal fee patent year 06
28.03.2008Renewal fee patent year 07
14.07.2009Renewal fee patent year 08
20.07.2010Renewal fee patent year 09
08.07.2011Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT19.10.2011
BE19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
FI19.10.2011
SE19.10.2011
SK19.10.2011
TR19.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
IE11.07.2012
LU11.07.2012
[2014/27]
Former [2014/21]AT19.10.2011
BE19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
FI19.10.2011
SE19.10.2011
SK19.10.2011
TR19.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
IE11.07.2012
Former [2013/33]AT19.10.2011
BE19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
FI19.10.2011
SE19.10.2011
SK19.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
IE11.07.2012
Former [2013/29]AT19.10.2011
BE19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
FI19.10.2011
SE19.10.2011
SK19.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2013/07]AT19.10.2011
BE19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
SE19.10.2011
SK19.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2012/36]BE19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
SE19.10.2011
SK19.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2012/35]BE19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
SE19.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2012/34]BE19.10.2011
CY19.10.2011
CZ19.10.2011
SE19.10.2011
GR20.01.2012
PT20.02.2012
Former [2012/28]BE19.10.2011
CY19.10.2011
SE19.10.2011
GR20.01.2012
PT20.02.2012
Former [2012/24]BE19.10.2011
SE19.10.2011
GR20.01.2012
PT20.02.2012
Former [2012/23]BE19.10.2011
GR20.01.2012
PT20.02.2012
Former [2012/21]BE19.10.2011
Documents cited:Search[PY]WO0195710  (NAKANISHI KENJI [JP], et al) [PY] 1-8,10 * the whole document *;
 [Y]  - MEE J B ET AL, "HUMAN KERATINOCYTES CONSTITUTIVELY PRODUCE BUT DO NOT PROCESS INTERLEUKIN-18", BRITISH JOURNAL OF DERMATOLOGY, XX, XX, (200008), vol. 143, no. 2, ISSN 0007-0963, pages 330 - 336, XP009065628 [Y] 1-8,10 * the whole document *

DOI:   http://dx.doi.org/10.1046/j.1365-2133.2000.03759.x
 [Y]  - YAMANAKA K ET AL, "SKIN-SPECIFIC CASPASE-1-TRANSGENIC MICE SHOW CUTANEOUS APOPTOSIS AND PRE-ENDOTOXIN SHOCK CONDITION WITH A HIGH SERUM LEVEL OF IL-18", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, (20000715), vol. 165, no. 2, ISSN 0022-1767, pages 997 - 1003, XP002946985 [Y] 1-8,10 * the whole document *
 [T]  - KONISHI HIROSHI ET AL, "IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, (20020820), vol. 99, no. 17, ISSN 0027-8424, pages 11340 - 11345, XP002378293 [T] 1-8,10 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.152337799
 [T]  - SHIOHARA T ET AL, "Animal models for atopic dermatitis: are they relevant to human disease?", JOURNAL OF DERMATOLOGICAL SCIENCE, ELSEVIER SCIENCE PUBLISHERS, SHANNON, IR, (200410), vol. 36, no. 1, ISSN 0923-1811, pages 1 - 9, XP004603012 [T] 1-8,10 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jdermsci.2004.02.013
International search[AP]WO0195710  (NAKANISHI KENJI [JP], et al);
 [A]  - YAMANAKA K. ET AL., J. IMMUNOL., (2000), vol. 165, pages 997 - 1003, XP002946985
 [A]  - HOSHINO T. ET AL., J. IMMUNOL., (20010615), vol. 166, pages 7014 - 7018, XP002956672
 [A]  - OSAKI T. ET AL., GENE THERAPY, (1999), vol. 6, pages 808 - 815, XP002956673

DOI:   http://dx.doi.org/10.1038/sj.gt.3300908
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.